Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.
Polen-De C, Giri S, Fadadu P, Weaver A, Mcgree ME, Moynagh M, Takahashi N, Jatoi A, Lebrasseur NK, Cliby W, Williams G, Kumar A.
Polen-De C, et al. Among authors: fadadu p.
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):43-48. doi: 10.1093/jncimonographs/lgad007.
J Natl Cancer Inst Monogr. 2023.
PMID: 37139982